Group 1 - The core viewpoint of the article highlights the strategic establishment of Ruisi Medical in Dongguan, leveraging the city's innovative environment to enhance the high-end medical equipment industry through its proprietary digital PET technology [1][2]. - Dongguan is characterized as a vibrant market with over 1.8 million market entities and a strong industrial ecosystem, providing a conducive environment for the development of AI technologies and related industries [2]. - Ruisi Medical's digital PET technology is positioned as a significant advancement in precision medicine, with the company holding the largest number of patents globally in this field, indicating its leadership in the industry [2][3]. Group 2 - Ruisi Medical has developed a diverse product line, including seven PET/CT devices and one brain-specific PET device, making it one of the most comprehensive manufacturers of PET equipment in China [3]. - The DigitMI 930, a fully digital PET/CT developed by Ruisi Medical, received regulatory approval in 2022 and is noted for its rapid imaging capabilities, completing scans in as little as 20 seconds, which is the fastest globally [3]. - The company aims to deepen its core research and promote the large-scale implementation of its products, addressing critical challenges in high-end medical devices and making advanced technology accessible to the public [3].